Prevalence of Type 2 Diabetes in China Rivals That of US, Europe, and Japan Combined
14th Nov 2006, 18:54 GMT
Type 2 Diabetes Drug Market in China to Grow to $1.3 Billion in 2010 Increasing Economic Power in China Has Led to More Patients Affording More-Expensive Western Branded Drugs, According to a New Report From Decision Resources
Prevalence of Type 2 Diabetes in China Rivals That of US, Europe, and Japan Combined related news:
- Type 2 Diabetes Epidemic In Asia — Health News from Medical News Today
- Sustained Reduction Of Type 2 Diabetes Achieved With Simple Lifestyle Interventions — Health News from Medical News Today
- Diabetes on the Rise Among Chinese — CRIENGLISH.com: China News
- Diabetes 'hitting poor hardest'. — Environmental Health News
- India worlds new diabetes epicentre: Lancet — The Indian Express
- Weight Loss Surgery Assists in Eliminating, Avoiding Type 2 Diabetes; American Institute of Gastric Banding Recognizes November as Nat'l Diabetes Month — Nephrology/ Dialysis News from StratCenter.com
- India diabetes capital — rediff.com
- Soy Yogurt may help control type 2 diabetes and high blood pressure — Slashfood
- Diabetes Fear For Poor Communities — Sky News: UK News, World News and Business News. The First for breaking global News!
- Diabetes rising among young, middle-aged Chinese: experts — NewKerala World News
Latest news from Pharmaceuticals News from StratCenter.com:
- Spectrum Pharmaceuticals to Receive $5 mln Milestone Payment From PAR Pharmaceutical for Sumatriptan Injection
- Medco to Present at the Credit Suisse Annual Healthcare Conference
- Bob Dole Medicare Podcast Helps Seniors through 2007 Drug Coverage Enrollment Process
- Unique Sugar Improves Energy, Pain and Quality of Life in Fibromyalgia and Chronic Fatigue Patients!
- Care Clinic Purchases Pinnacle Easy Care
- Pegasystems Enhances 2 Business Critical BPM Frameworks for the Healthcare Industry
- Isis Cholesterol Drug Shown Effective
- Taro Receives Marketing Authorization in UK for Etopan XL Tablets 600 mg, Etodolac
- Nymox Reports Q3 2006 Financial Results
- RemoteMDx Raises $6 mln in Private Placement